Evaluation of enhanced delivery and newborn kits for safer childbirth
Evaluation of the Impact of Enhanced Delivery and Newborn Kits as Compared to Standard Delivery Kits in the Flood Affected Districts of Sindh and Balochistan Provinces: A Cluster Randomized Trial
This study is testing whether special delivery and newborn kits can help pregnant women in flood-affected areas have safer childbirths and improve the health of their babies.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 2400 (estimated) |
| Sex | All |
| Sponsor | Aga Khan University Academic / other |
| Locations | 1 site (Karachi, Sindh) |
| Trial ID | NCT05640063 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of enhanced delivery and newborn kits compared to standard kits in flood-affected districts. It aims to increase service utilization and reduce delays that negatively impact maternal and newborn health through a community health worker program. The focus is on addressing the high rates of perinatal death by providing essential tools and interventions during childbirth. The study targets pregnant women in these areas to assess the impact of these kits on health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women living in flood-affected areas until their expected delivery date.
Not a fit: Patients who do not consent to participate in the study will not receive any benefit from this intervention.
Why it matters
Potential benefit: If successful, this could significantly reduce perinatal mortality and improve maternal health outcomes in crisis-affected regions.
How similar studies have performed: Other studies have shown success with similar interventions aimed at improving maternal and newborn health in resource-limited settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women in the project sites living in the area till expected date of their delivery. Exclusion Criteria: * The individuals who would not consent to participate in the study voluntarily.
Where this trial is running
Karachi, Sindh
- Aga Khan University — Karachi, Sindh, Pakistan (Recruiting)
Study contacts
- Study coordinator: Zahid Memon, MPH
- Email: zahid.memon@aku.edu
- Phone: 03085550859
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.